Back
CASI Pharmaceuticals, Inc. 10K Form
Sell
14
CASI
CASI Pharmaceuticals, Inc.
Last Price:
$0.97
Seasonality Move:
7.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CASI News And Ratings
See the #1 stock for the next 7 days that we like better than CASI
CASI Financial Statistics
Sales & Book Value
| Annual Sales: | $28.5M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-1.66 |
| Price / Book: | 15.65 |
Profitability
| EPS (TTM): | -3.16210 |
|---|---|
| Net Income (TTM): | $-49.4M |
| Gross Margin: | $11.1M |
| Return on Equity: | -70405.41% |
| Return on Assets: | -112.93% |
CASI Pharmaceuticals, Inc. Earnings Forecast
Key CASI Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for CASI is 38.99%.
-
The Selling, General & Administrative Expenses for CASI have been equal to 145.23% of Gross Profit Margin.
-
The Research & Development expenses have been 31.18% of Revenue.
-
The Net Earning history of CASI is -137.57% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 15 years.
CASI Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CASI |
| CUSIP: | 14757U |
| Website: | casipharmaceuticals.com |
Debt
| Debt-to-Equity Ratio: | -0.73 |
|---|---|
| Current Ratio: | 0.3 |
| Quick Ratio: | 0.19 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CASI Technical Analysis vs Fundamental Analysis
Sell
14
CASI Pharmaceuticals, Inc. (CASI)
is a Sell
Is CASI Pharmaceuticals, Inc. a Buy or a Sell?
-
CASI Pharmaceuticals, Inc. stock is rated a SellThe current CASI Pharmaceuticals, Inc. [CASI] share price is $0.98. The Score for CASI is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.